纳米药物开发的监管：化学制造和控制角度的法规解析
汪冠宇，JIA Audrey，袁 丹，王云翃，王 勇*
Regulatory Perspective of the CMC Considerations for Nanodrug Development
WANG Guanyu, JIA Audrey, YUAN Dan, WANG Yunhong, WANG Yong*
.
2019, (10): 1215
-1227
.
DOI: 10.16522/j.cnki.cjph.2019.10.015
